Panacea Index Logo

Command Palette

Search for a command to run...

Vitamin D Dosing: Basic Principles and a Brief Algorithm (2021 Update).

Nutrients
January 1, 1970
Andrius Bleizgys
Journal ArticleReviewHuman Study
Study Details

Study Goal

The researchers aimed to propose a practical approach for vitamin D supplementation when immediate 25OH-D level testing is unavailable, such as during COVID-19 quarantine.

Results Summary

The study suggests that moderate vitamin D doses (e.g., 4000 IU/day for adults) can be safely initiated without prior testing, with 25OH-D levels checked later. It also outlines dosing principles when baseline levels are known.

Population

Adults at risk of low vitamin D levels, particularly COVID-19 outpatients under quarantine.

Effective Dosage

4000 IU/day for adults

Duration

Not specified

Interactions

None mentioned

Extracted Claims (3)
InterventionDirectionEndpointPopulationDosageImpactClaim #
vitamin D supplementation
neutral
serum 25-hydroxy-vitamin D (25OH-D) levels
many people at high risk to have low vitamin D levels
-
should be performed before prescribing
#1
moderate vitamin D doses (e.g., 4000 IU/day)
neutral
25-OH-D levels
COVID-19 outpatients under mandatory quarantine
-
could be advised to start taking
#2
vitamin D dosing principles
neutral
baseline 25OH-D levels
-
-
comprises
#3
Abstract

Nowadays, in modern societies, many people can be at high risk to have low vitamin D levels. Therefore, testing of serum 25-hydroxy-vitamin D (25OH-D) levels should be performed before prescribing them vitamin D supplementation. However, in some cases the 25OH-D level assessment is not available at the right moment, e.g., due to mandatory quarantine of COVID-19 outpatients. Therefore, such patients could be advised to start taking moderate vitamin D doses (e.g., 4000 IU/day for adults), and their 25-OH-D levels could be checked later. The proposed algorithm also comprises vitamin D dosing principles when baseline 25OH-D levels are known.

Medical Subject Headings (MeSH)
AdultAlgorithmsCOVID-19HumansSARS-CoV-2Vitamin DCOVID-19 Drug Treatment
Study Links
Quality Scores
Safety80
Efficacy70/10
Quality60/10
Citation Metrics
Total Citations34
Citations/Year8.5
Relative Citation Ratio3.75
NIH Percentile89.1%
Research Impact Scores
APT Score0.75
Weight Score0.77
Normalized Score0.72
Related Supplements